How Specialty Pharmacy Growth is Hurting Wholesalers

McKesson recently released its quarterly earnings for the fourth calendar quarter of 2017. Learn more on the three interrelated mix changes that challenge wholesalers’ profits from the growth of specialty pharmacy drugs. (Source: Drug Channels, 2/6/18)

You might also be interested in:

McKesson’s Sarah Alwardt Expands on HEOR, Value of RWE April 4, 2018
Report: Insurers Found Solid Footing in Second Quarter August 9, 2018
Pharma Mostly Posts Lower Prices in Q4 of 2017 April 5, 2018
Thaler Talks Ways to Break Down Biases in Business World,… May 27, 2018
AstraZeneca CEO: Company Back on Course for Long-term Growth November 9, 2018
PhRMA: Health Affairs Study ‘Overestimates’ Role… January 29, 2019
Express Scripts Formulary Has Hep C, MS Exclusions August 20, 2018